Academic · Private company
Global Alliance for TB Drug Development
Track this companyFree. Adds Global Alliance for TB Drug Development to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials5
- A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy AdultsPHASE1 · COMPLETED · started Jun 30, 2022ClinicalTrials.gov NCT05526911 · fetched Nov 12, 2026
- Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy SubjectsPHASE1 · COMPLETED · started Feb 3, 2021ClinicalTrials.gov NCT04865536 · fetched Nov 12, 2026
- Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy AdultsPHASE1 · COMPLETED · started Jun 8, 2020ClinicalTrials.gov NCT04493671 · fetched Nov 12, 2026
- Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of PretomanidPHASE1 · COMPLETED · started Jan 14, 2020ClinicalTrials.gov NCT04309656 · fetched Nov 12, 2026
- A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy AdultsPHASE1 · COMPLETED · started Jan 16, 2019ClinicalTrials.gov NCT03758612 · fetched Nov 12, 2026